Trials / Completed
CompletedNCT01865890
Prevalence of Clopidogrel (Plavix) Resistance in Hemodialysis Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (actual)
- Sponsor
- Northwell Health · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The investigators are trying to find out if Clopidogrel (Plavix) is as effective in hemodialysis patients as in patients not hemodialysed.
Detailed description
Cardiovascular disease is very frequent in hemodialysis patients. Lot of hemodialysis patients are on Clopidogrel (plavix). Their is some evidence that clopidogrel is not effective in hemodialysis as it is effective in patient without kidney problem. VerifyNow plavix is a machine that measure the ability of the blood to clot after giving plavix. We will collect blood from hemodialysis patients on plavix and check the ability of their blood to clot and thus indirectly measuring the efficacy of Plavix.
Conditions
Timeline
- Start date
- 2010-06-01
- Primary completion
- 2011-04-01
- Completion
- 2011-04-01
- First posted
- 2013-05-31
- Last updated
- 2013-05-31
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01865890. Inclusion in this directory is not an endorsement.